The Richmond Club

XORTX Therapeutics Inc.

Biotech  XORTX Therapeutics Inc. is a biopharmaceutical company focused on developing innovative therapies to treat progressive kidney disease. XORTX has lead programs to develop treatments for progressive kidney disease due to diabetes, diabetic nephropathy and polycystic kidney disease with secondary programs focused on developing therapies for health consequences that accompany pre-diabetes, diabetes and cardiovascular disease. At XORTX Therapeutics, we are dedicated to developing medications to improve the quality of life and future health of patients.  

Learn more at
http://www.xortx.com
adavidoff@xortx.com
1 403 607-2621

The Richmond Review

First page of slide deck

Fri Feb 14th, 2020

  • SEC Filings3:00 AM

    [Amend] Statement of acquisition of beneficial ownership by individuals – Form SC 13G/A

  • SEC Filings3:00 AM

    [Amend] Statement of acquisition of beneficial ownership by individuals – Form SC 13G/A

Get Access to The Richmond Clubs Latest Stock Picks

 

Don’t miss your chance to get in on the top stocks we think are the best buys now inside our exclusive Richmond Club Stock Advisor Letter.

Led by Chartered Investment Manager, Greg Beckett, the average stock pick inside The Richmond Club is up 1,301% vs. just 153% for the S&P.

This is your opportunity to become part of an exclusive membership led by the Richmond Club that has seen an average of 16.45 % gains over the past 15 years!

If you want to take advantage of this buying opportunity, simply enter your email address below to access our secure sign-up page.

By submitting your email address, you consent to us keeping you informed about updates to our website and about other products and services that we think might interest you. You can unsubscribe at any time. Please read our Privacy Policy